期刊
SCIENCE TRANSLATIONAL MEDICINE
卷 14, 期 648, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.abq7374
关键词
-
资金
- Aligning Science Across Parkinson's through the Michael J. Fox Foundation for Parkinson's Research [ASAP-000478]
A phase 1 clinical trial for kinase inhibitors targeting LRRK2 lays the groundwork for evaluating the effectiveness of LRRK2 kinase inhibitors in Parkinson's disease.
A phase 1 clinical trial for kinase inhibitors targeting LRRK2 provides the foundation for testing the efficacy of LRRK2 kinase inhibitors in Parkinson's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
